Axsome Therapeutics Inc (AXSM)

03:02 AM

Why (AXSM) Price Action Is Critical for Tactical Trading - Stock Traders Daily

03:02 AM

Feb 09, 2026

Axsome Therapeutics (AXSM) Stock Analysis: A 63% Revenue Growth Fuels a Promising Biotech Play - DirectorsTalk Interviews

Feb 09, 2026

Feb 07, 2026

Morgan Stanley Remains Bullish on Axsome (AXSM), Reiterates $190 PT - MSN

Feb 07, 2026

Feb 06, 2026

Should You Buy Axsome Therapeutics Stock Before Feb. 23? - AOL.com

Feb 06, 2026

Feb 06, 2026

Auvelity Priority Review And Revenue Update Could Be A Game Changer For Axsome Therapeutics (AXSM) - Sahm

Feb 06, 2026

Feb 05, 2026

Best Biotech Stocks of 2026 and How to Invest in Them - The Motley Fool

Feb 05, 2026

Feb 05, 2026

Johnson Fistel, PLLP Investigates Claims on Behalf of - GlobeNewswire

Feb 05, 2026

Feb 05, 2026

Axsome Therapeutics Stock Soars 75% Amid Strong Growth - Intellectia AI

Feb 05, 2026

Feb 05, 2026

Principal Financial Group Inc. Acquires 12,923 Shares of Axsome Therapeutics, Inc. $AXSM - MarketBeat

Feb 05, 2026

Feb 04, 2026

Hot Picks: Small-cap pharma stocks in focus as key drug approvals near - BNN Bloomberg

Feb 04, 2026

Feb 04, 2026

The Bull Case For Axsome Therapeutics (AXSM) Could Change Following Strong Auvelity Sales And Alzheimer’s Label Hopes - Yahoo Finance

Feb 04, 2026

Feb 03, 2026

Axsome Therapeutics says AXS-12 NDA submission on track for January - MSN

Feb 03, 2026

Feb 03, 2026

1 High-Flying Stock With More Upside Ahead - Finviz

Feb 03, 2026

Feb 03, 2026

Axsome Therapeutics (AXSM) Reports 66% Revenue Growth in FY2025, Beats Analyst Estimates - Finviz

Feb 03, 2026

Feb 03, 2026

Axsome Therapeutics (NASDAQ:AXSM) Given New $245.00 Price Target at Jefferies Financial Group - MarketBeat

Feb 03, 2026

Feb 03, 2026

Axsome Therapeutics (AXSM) reports 66% revenue growth in FY2025, beats analyst estimates - MSN

Feb 03, 2026

Feb 03, 2026

Axsome Therapeutics, Inc. (AXSM) Investor Outlook: Strong Buy Ratings and Promising 15.71% Potential Upside - DirectorsTalk Interviews

Feb 03, 2026

Feb 02, 2026

Axsome Therapeutics (NASDAQ:AXSM) CEO Sells $6,015,296.00 in Stock - MarketBeat

Feb 02, 2026

Feb 02, 2026

Axsome Therapeutics CEO Tabuteau sells $6.0m in shares By Investing.com - Investing.com Canada

Feb 02, 2026

Feb 02, 2026

Biggest stock movers Wednesday: Vanda Pharmaceuticals, Axsome Therapeutics and Cybin - MSN

Feb 02, 2026

Feb 02, 2026

Axsome Therapeutics AXS-05 Alzheimer's Launch Could Drive Upside, RBC Says - marketscreener.com

Feb 02, 2026

Feb 02, 2026

Axsome Therapeutics stock maintains Outperform rating at RBC on ADA approval potential - Investing.com Canada

Feb 02, 2026

Feb 01, 2026

Understanding Momentum Shifts in (AXSM) - Stock Traders Daily

Feb 01, 2026

Jan 31, 2026

Top Investors’ Stock Portfolio: 10 Mid-cap Stocks To Buy - Insider Monkey

Jan 31, 2026

Jan 29, 2026

J. Safra Sarasin Holding AG Has $1.08 Million Stake in Axsome Therapeutics, Inc. $AXSM - MarketBeat

Jan 29, 2026

Jan 28, 2026

AXSM: Leerink Partners Raises Price Target to $205, Maintains Ou - GuruFocus

Jan 28, 2026

Jan 28, 2026

Leerink Partners Issues Positive Forecast for Axsome Therapeutics (NASDAQ:AXSM) Stock Price - MarketBeat

Jan 28, 2026

Jan 27, 2026

Revenues Tell The Story For Axsome Therapeutics, Inc. (NASDAQ:AXSM) - 富途牛牛

Jan 27, 2026

Jan 27, 2026

Axsome Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on February 23 - The Manila Times

Jan 27, 2026

Jan 27, 2026

Axsome Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on February 23, 2026 - Quiver Quantitative

Jan 27, 2026

Jan 26, 2026

Is Axsome Therapeutics Inc attractive for institutional investors2025 Volatility Report & Safe Swing Trade Setup Alerts - baoquankhu1.vn

Jan 26, 2026

Jan 26, 2026

Auvelity Continues to Aid AXSM's Top Line: More Upside in 2026? - sharewise.com

Jan 26, 2026

Jan 26, 2026

Universal Beteiligungs und Servicegesellschaft mbH Increases Position in Axsome Therapeutics, Inc. $AXSM - MarketBeat

Jan 26, 2026

Jan 26, 2026

Cabot Wealth Management Inc. Buys Shares of 5,560 Axsome Therapeutics, Inc. $AXSM - MarketBeat

Jan 26, 2026

Jan 25, 2026

Axsome Therapeutics, Inc. (NASDAQ:AXSM) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat

Jan 25, 2026

Jan 24, 2026

Axsome Therapeutics: A Conditional Buy Built On SG&A Discipline (NASDAQ:AXSM) - Seeking Alpha

Jan 24, 2026

Jan 23, 2026

Ari Maizel, chief commercial officer of Axsome, sells $1.38m in shares By Investing.com - Investing.com Nigeria

Jan 23, 2026

Jan 23, 2026

Ari Maizel, chief commercial officer of Axsome, sells $1.38m in shares - Investing.com UK

Jan 23, 2026

Jan 23, 2026

Pizzie, Axsome Therapeutics CFO, sells $2.25m in shares By Investing.com - Investing.com Canada

Jan 23, 2026

Jan 23, 2026

Insider Selling: Axsome Therapeutics (NASDAQ:AXSM) Insider Sells 7,500 Shares of Stock - MarketBeat

Jan 23, 2026

Jan 23, 2026

Axsome Therapeutics (NASDAQ:AXSM) CFO Sells $2,255,040.00 in Stock - MarketBeat

Jan 23, 2026

Jan 23, 2026

How The New Price Target Is Shaping The Axsome Therapeutics (AXSM) Investment Story - Yahoo Finance

Jan 23, 2026

Jan 23, 2026

MoneyShow Top Picks 2026: Axsome Therapeutics Inc. (AXSM) - Barchart.com

Jan 23, 2026

Jan 23, 2026

Analysts Conflicted on These Healthcare Names: Hinge Health, Inc. Class A (HNGE), Axsome Therapeutics (AXSM) and TG Therapeutics (TGTX) - The Globe and Mail

Jan 23, 2026

Jan 23, 2026

Assessing Axsome Therapeutics (AXSM) Valuation After Analyst Upgrades And Pipeline Progress - Yahoo Finance

Jan 23, 2026

Jan 23, 2026

Axsome begins phase III AXS-14 Forward trial for fibromyalgia management - MSN

Jan 23, 2026

Jan 23, 2026

(01/23/26) Top Picks 2026: Axsome Therapeutics Inc. (AXSM) - moneyshow.com

Jan 23, 2026

Jan 22, 2026

Piper Sandler Bullish on Axsome Therapeutics (AXSM) Ahead of Likely Auvelity Label Expansion by April 30 - Insider Monkey

Jan 22, 2026

Jan 22, 2026

FY2025 Earnings Forecast for AXSM Issued By HC Wainwright - MarketBeat

Jan 22, 2026